Marco Lanzillotta
Vita-Salute San Raffaele University
EpidemiologyInternal medicinePathologyCD20RheumatologyNaive B cellCohort studyImmunologyBiopsyAutoimmune pancreatitisB cellCD19DiseaseIgG4-related diseaseFibrosisRituximabDifferential diagnosisGlucocorticoidMethotrexateCancer researchMedicineCohortGastroenterology
60Publications
16H-index
912Citations
Publications 59
Newest
#1Gaia MancusoH-Index: 3
#2Tatiana JofraH-Index: 9
Last. E. Della TorreH-Index: 2
view all 8 authors...
Source
Source
Source
#1Marco LanzillottaH-Index: 16
#2G. CapursoH-Index: 2
Last. E. Della TorreH-Index: 2
view all 6 authors...
Source
#1Emanuel Della-Torre (UniSR: Vita-Salute San Raffaele University)H-Index: 27
#2Marco Lanzillotta (UniSR: Vita-Salute San Raffaele University)H-Index: 16
Last. Lorenzo Dagna (UniSR: Vita-Salute San Raffaele University)H-Index: 37
view all 8 authors...
ABSTRACT Background The 2019 ACR/EULAR Classification Criteria for IgG4-related disease (IgG4-RD) represent a fundamental tool for patient enrollment in research studies and in clinical trials but their usefulness in daily clinical practice remains unknown. Objective To validate the 2019 ACR/EULAR Classification Criteria for IgG4-RD in a real-life setting and to anticipate their utility for orienting disease diagnosis and patient management. Methods Four experts were asked to classify 200 patien...
Source
#1Emanuel Della-Torre (UniSR: Vita-Salute San Raffaele University)H-Index: 27
#2Marco Lanzillotta (UniSR: Vita-Salute San Raffaele University)H-Index: 16
Last. Lorenzo Dagna (UniSR: Vita-Salute San Raffaele University)H-Index: 37
view all 16 authors...
Background. Restraining maladaptive inflammation is considered a rationale strategy to treat severe COVID-19 but available studies with selective inhibitors of pro-inflammatory cytokines have not provided unequivocal evidence of survival advantage. Late administration is commonly regarded as a major cause of treatment failure but the optimal timing for anti-cytokine therapy initiation in COVID-19 patients has never been clearly established. Objectives. To identify a window of therapeutic opportu...
Source
#1Gaia Mancuso (UniSR: Vita-Salute San Raffaele University)H-Index: 3
#2Tatiana JofraH-Index: 9
Last. Emanuel Della-Torre (UniSR: Vita-Salute San Raffaele University)H-Index: 27
view all 9 authors...
Source
#1Marco Lanzillotta (UniSR: Vita-Salute San Raffaele University)H-Index: 16
#2Andreu Fernández-Codina (UWO: University of Western Ontario)H-Index: 10
Last. Emanuel Della-Torre (UniSR: Vita-Salute San Raffaele University)H-Index: 27
view all 7 authors...
INTRODUCTION Awareness of IgG4-related disease (IgG4-RD) is increasing worldwide and specialists are now familiar with most of its clinical manifestations and mimickers. IgG4-RD promptly responds to glucocorticoids and repeated courses are typically used to induce and maintain remission because the disease relapses in most patients. If left untreated it can lead to organ dysfunction, organ failure and death. Advancement in our understanding of IgG4-RD pathogenesis is leading to the identificatio...
Source
#1Marco Ripa (UniSR: Vita-Salute San Raffaele University)H-Index: 10
#2Laura GalliH-Index: 33
Last. Concetta VinciH-Index: 5
view all 82 authors...
Abstract Objectives The aim of our study was to describe the incidence and predictive factors of secondary infections in patients with coronavirus disease 2019 (COVID-19). Methods This was a cohort study of patients hospitalized with COVID-19 at IRCCS San Raffaele Hospital between 25th February and 6th April 2020 (NCT04318366). We considered secondary bloodstream infections (BSIs) or possible lower respiratory tract infections (pLRTIs) occurring 48 hours after hospital admission until death or d...
11 CitationsSource
#1Marco Lanzillotta (UniSR: Vita-Salute San Raffaele University)H-Index: 16
#2Miriam Sant'Angelo (UniSR: Vita-Salute San Raffaele University)
Last. Emanuel Della-Torre (UniSR: Vita-Salute San Raffaele University)H-Index: 27
view all 6 authors...
Source